A carregar...
Clinical Development of c-MET Inhibition in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death. In patients with advanced or unresectable HCC, there are few treatment options. Conventional chemotherapy has limited benefits. Sorafenib, a multi-kinase inhibitor, improves survival, but options for patients intolerant of...
Na minha lista:
| Publicado no: | Diseases |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5548260/ https://ncbi.nlm.nih.gov/pubmed/28943627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diseases3040306 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|